Environmental risk assessment for the widely used iodinated X-ray contrast agent iopromide (ultravist)

Ecotoxicology and Environmental Safety

Volumn 42, Issue 3, 1999, Pages 274-281

  Steger Hartmann, T ^a   Lange R ^a   Schweinfurth, H ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IODINATED CONTRAST MEDIUM; IOPROMIDE; SURFACE WATER;

ACUTE TOXICITY; ALGA; ARTICLE; BIODEGRADATION; CHEMICAL STRUCTURE; CHRONIC TOXICITY; CONTROLLED STUDY; DAPHNIA; ECOTOXICITY; ENVIRONMENTAL IMPACT ASSESSMENT; ENVIRONMENTAL MONITORING; FISH; GROWTH INHIBITION; IMMOBILIZATION; NONHUMAN; POLLUTANT; PSEUDOMONAS; REPRODUCTION; RISK ASSESSMENT; TOXICITY TESTING;

ALGAE; ANIMALIA; CRUSTACEA; DANIO RERIO; DAPHNIA; DAPHNIA MAGNA; DESMODESMUS SUBSPICATUS; LEUCISCUS IDUS; PSEUDOMONAS; PSEUDOMONAS PUTIDA; SCENEDESMUS; VIBRIO; VIBRIO FISHERI;

EID: 0043193163     PISSN: 01476513     EISSN: None     Source Type: Journal    
DOI: 10.1006/eesa.1998.1759     Document Type: Article

References (26)

1. Barke R. Stoffwechselverhalten der Jodkontrastmittel. Röntgenkontrastmittel Chemie-Physiologie-Klinik. 1970;VEB G. Thieme, Leipzig. p. 95-116.
2. Dawson P. Structure-toxicity relationship and molecule design. Contrast Media in Practice. 1993;Springer-Verlag, Berlin Heidelberg. p. 12-20.
3. Deutsche Einheitsverfahren zur Wasser-, Abwasser- und Schlammuntersuchung; Testverfahren mit Wasserorganismen (Gruppe L). 1982.
4. Deutsche Einheitsverfahren zur Wasser-, Abwasser- und Schlammuntersuchung; Testverfahren mit Wasserorganismen (Gruppe L). 1989.
5. Deutsche Einheitsverfahren zur Wasser-, Abwasser- und Schlammuntersuchung; Testverfahren mit Wasserorganismen (Gruppe L). 1991a.
6. Deutsche Einheitsverfahren zur Wasser-, Abwasser- und Schlammuntersuchung; Testverfahren mit Wasserorganismen (Gruppe L). 1991b.
7. European Commission, 1995, Assessment of Potential Risks to the Environment Posed by Medicinal Products for Human Use (Excludig Products Containing Live Genetically Modified Organisms): Phase 1 environmental risk assessment, III/5504/94-Draft 7, Brussels.
8. Fed. Regist. 61:1996;14922-14942.
9. Gartiser S., Brinker L., Erbe T., Kümmerer K., Willmund R. Contamination of hospital wastewater with hazardous compounds as defined by §7a WHG. Acta Hydrochim. Hydrobiol. 24:1996;90-97.
10. Hartwig P., Mützel W., Taenzer V. Pharmacokinetics of iohexol, iopamidol, iopromide, and iosimide compared with meglumine diatrizoate. Taenzer V., Wende S. Recent Developments in Nonionic Contrast Media. 1989;220-223 G. Thieme Verlag, Stuttgart New York.
11. Herrmann D. Which factors reduce the stability of contrast media and what are the implications of storage recommendations? Dawson P., Clauss W. Contrast Media in Practice. 1993;44-47 Springer-Verlag, Berlin Heidelberg.
12. Keysser R. Survey of the clinical trial programme with Ultravist. Felix R., Fischer H. W. Contrast Media from the Past to the Future. 1987;41-51 G. Thieme Verlag, Stuttgart.
13. Maurer H. J., Clauss W. A historical overview of the development of contrast media for diagnostic imaging procedures in radiology. Dawson P., Clauss W. Contrast Media in Practice. 1993;1-6 Springer-Verlag, Berlin Heidelberg.
14. Mützel W., Langer M., Keysser R. Renal excretion of iopromide and iopamidol after intravenous administration in digital subtraction angiography. Taenzer V., Wende S. Recent Developments in Nonionic Contrast Media. 1989;101-104 G. Thieme Verlag, Stuttgart.
15. Nyholm N. The European system of standardized legal tests for assessing the biodegradability of chemicals. Environ. Toxicol. Chem. 10:1991;1237-1246.
16. OECD, 1984a, Guideline for the Testing of Chemicals: Daphnia sp, Acute Immobilisation Test and Reproduction Test, OECD 202, Paris.
17. OECD, 1984b, Guideline for the Testing of Chemicals: Fish, Acute Toxicity Test, OECD 203, Paris.
18. OECD, 1993a, Guideline for the Testing of Chemicals: Vapour Pressure, Appendix: Estimation Method, OECD 104, Paris.
19. OECD, 1993b, Guideline for the Testing of Chemicals: Modified OECD Screening Test, OECD 301E, Paris.
20. Olejniczak K. Environmental risk assessment for medicinal products in the EU, phase I. Environmental Risk Assessment for Pharmaceuticals and Veterinary Medicines. 1995;RCC - Research & Consulting Company Ltd. Itingen. p. 58-65.
21. Oleksy-Frenzel J., Wischnack., Jekel M. Determination of organic group parameters AOCI, AOBr and AOI in municipal waste water. Vom Wasser. 85:1995;59-67.
22. Richardson M. L., Bowron J. M. The fate of pharmaceutical chemicals in the aquatic environment. J. Pharm. Pharmacol. 37:1985;1-12.
23. Rosenberg, D. Rehmann, I. Gloege, C. 1994, Der Verbleib von Iopromid in der Umwelt, Schering Report, SPA 08/94, 1, 15.
24. Schöbel C., Günzel P. Results of toxicological tests assessing the risk of nonionic contrast media in human. Dawson P., Clauss W. Contrast Media in Practice. 1993;12-20 Springer-Verlag, Berlin Heidelberg.
25. Stan H.-J., Heberer T., Linkerhägner M. Vorkommen von Clofibrinsäure im aquatischen System: Führt die therapeutische Anwendung zu einer Belastung von Oberflächen-, Grund- und Trinkwasser. Vom Wasser. 83:1994;57-68.
26. Steger-Hartmann T., Kümmerer K., Hartmann A. Biological degradation of cyclophosphamide and its occurrence in sewage water. Ecotoxicol. Environ. Saf. 36:1997;74-179.